Health
Can Moderna shares rally on higher vaccine efficacy against Delta variant? – ig.com
Covid-19 vaccine maker Moderna’s stock has been on a tear this year, hitting record highs.
- Moderna (Nasdaq: MRNA) share price falls to US$456.76 per share
- The US biotech said it will not exceed its 2021 vaccine production target
- Modernas jab may be more effective against the Delta variant than its rivals shot, a study suggested
- Feeling bullish or…
Continue Reading
-
General24 hours agoTed O’Brien was all over Chris Bowen like a wind turbine on an endangered bird
-
General23 hours agoPM, Deputy PM at odds over NZ response to US tariffs
-
Noosa News23 hours agoWoman gives birth to stranger’s baby after receiving wrong embryo at Monash IVF
-
General24 hours agoCorporate tax avoidance. Who helps fund Australia, and who doesn’t?